Pharmacy benefit managers, or PBMs, are the middlemen that decide which medicines people get at their local drugstore. In many states, just a handful of PBMs own the majority of prescription business. This means they have a lot of power over drug prices and what doctors can prescribe. The situation
In the United States, around 8 million individuals rely on insulin to manage their diabetes. However, the cost of insulin has skyrocketed over the past decade, leaving many patients unable to afford the life-saving medication. The Federal Trade Commission (FTC) has taken a bold step to address this
In the world of medicine, the cost of living with diabetes is skyrocketing, and it's not just because of the drugs themselves. A recent lawsuit filed by the Federal Trade Commission (FTC) against three major pharmacy benefit managers (PBMs) sheds light on a more sinister force driving up insulin pri
The American healthcare system has long been plagued by issues of affordability, but a recent Federal Trade Commission (FTC) lawsuit has brought attention to a particularly egregious example: pharmacy benefit managers (PBMs) allegedly inflating insulin prices at the expense of patients. The three la
